KK

Kamlesh Kumar

Director Director DIN 07257503
DIN 07257503 First appointment Aug 2015 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Aug 2015
Shareholding value •••• Premium profile

About Kamlesh Kumar

Data last updated:

Kamlesh Kumar was a Director at Coleus Laboratories Private Limited (2018–2021) and Director at Dbott Biotec Private Limited (2015–2018). The companies operate in Healthcare and Chemicals.

DIN 07257503
Primary Designation Director
Industry Healthcare
First Appointment 20 Aug 2015

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Coleus Laboratories Private Limited U24304WB2018PTC224248
Director10 Jan 20182018₹9.3 Lakh (FY 2025)Active
Dbott Biotec Private Limited U24233DL2012PTC242650
Director20 Aug 20152012₹2.51 Cr (FY 2024)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Coleus Laboratories Private Limited
Dbott Biotec Private Limited
Premium access

Shareholding and investment profile for Kamlesh Kumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kamlesh Kumar

Kamlesh Kumar was first appointed on 20 Aug 2015 as Director at Dbott Biotec Private Limited. The most recent appointment on record is 10 Jan 2018 at Coleus Laboratories Private Limited.

Kamlesh Kumar held 2 earlier board appointments: Coleus Laboratories Private Limited (Director, 10 Jan 2018 to 26 Dec 2021); Dbott Biotec Private Limited (Director, 20 Aug 2015 to 15 Feb 2018).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available